Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Boehringer Ingelheim and partner Eli Lilly are celebrating the news that regulators in Europe have given the green light to their once-daily type 2 diabetes pill Trajenta
http://www.pharmatimes.com/Article/11-08-26/Boehringer_Lilly_s_diabetes_drug_gets_Europe_OK.aspx
http://www.pharmatimes.com/Article/11-08-26/Boehringer_Lilly_s_diabetes_drug_gets_Europe_OK.aspx